These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 139208)

  • 21. Morphological observations on the contact-induced lysis of target cells.
    Koren HS; Ax W; Freund-Moelbert E
    Eur J Immunol; 1973 Jan; 3(1):32-7. PubMed ID: 4197969
    [No Abstract]   [Full Text] [Related]  

  • 22. T-lymphocyte mediated lysis of tumor cells in the presence of alloantiserum.
    Liepins A; Faanes RB; Choi YS; de Harven E
    Cell Immunol; 1978 Mar; 36(2):331-44. PubMed ID: 415815
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T cells in mixed-lymphocyte-culture-induced cytolysis (MLC-CML).
    Häyry P; Andersson LC
    Transplant Proc; 1973 Dec; 5(4):1697-703. PubMed ID: 4272824
    [No Abstract]   [Full Text] [Related]  

  • 26. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observations on the mechanism by which T-lymphocytes exert cytotoxic effects.
    Ferluga J; Allison AC
    Nature; 1974 Aug; 250(5468):673-5. PubMed ID: 4212208
    [No Abstract]   [Full Text] [Related]  

  • 29. Leukemia virus-induced immunosuppression. X. Depression of T cell-mediated cytotoxicity after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1974 Jun; 112(6):2077-86. PubMed ID: 4207729
    [No Abstract]   [Full Text] [Related]  

  • 30. Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization.
    MacDonald HR; Phillips RA; Miller RG
    J Immunol; 1973 Aug; 111(2):565-74. PubMed ID: 4123983
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation.
    Gorczynski RM; Tigelaar RE
    Cell Immunol; 1975 Jul; 18(1):121-43. PubMed ID: 806353
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigen-T lymphocyte interactions: inhibition by cytochalasin B.
    Henney CS; Bubbers JE
    J Immunol; 1973 Jul; 111(1):85-90. PubMed ID: 4197336
    [No Abstract]   [Full Text] [Related]  

  • 33. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
    Abbasi K; Festenstein H; Verbi W; Roitt IM
    Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
    [No Abstract]   [Full Text] [Related]  

  • 34. Regulation of the immune response. VIII. Characteristics of antibody-mediated suppression of an in vitro cell-mediated immune response.
    Sinclair NR; Lees RK; Fagan G; Birnbaum A
    Cell Immunol; 1975 Apr; 16(2):330-47. PubMed ID: 803878
    [No Abstract]   [Full Text] [Related]  

  • 35. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
    Takei F; Levy JG; Kilburn DG
    J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and identification of the naturally occurring, newborn spleen-associated suppressor cells. A mixed monocyte/mast cell population with separable suppressor activities.
    Peeler K; Wigzell H; Peck AB
    Scand J Immunol; 1983 May; 17(5):443-53. PubMed ID: 6222470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-forming cells with specificity for syngeneic and allogeneic (thymocyte) tissue antigens following lipopolysaccharide mitogenic stimulation.
    McHugh YH; Bonavida B
    Transplant Proc; 1977 Mar; 9(1):1205-9. PubMed ID: 68566
    [No Abstract]   [Full Text] [Related]  

  • 38. Synergy among thymocytes and peripheral lymph node cells in the in vitro generation of lymphocytes cytotoxic to alloantigens.
    Tigelaar RE; Feldmann M
    Transplant Proc; 1973 Dec; 5(4):1711-5. PubMed ID: 4272825
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo.
    Sabbadini E
    Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymus cell subpopulations separated on discontinuous BSA gradients: antigenic properties and circulation capacity.
    Schlesinger M; Gottesfeld S; Korzash Z
    Cell Immunol; 1973 Jan; 6(1):49-58. PubMed ID: 4684524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.